Daniel Soffer

760 total citations
30 papers, 508 citations indexed

About

Daniel Soffer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Daniel Soffer has authored 30 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 5 papers in Internal Medicine. Recurrent topics in Daniel Soffer's work include Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Lipoproteins and Cardiovascular Health (10 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Daniel Soffer is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Lipoproteins and Cardiovascular Health (10 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Daniel Soffer collaborates with scholars based in United States, Italy and Austria. Daniel Soffer's co-authors include Francesco Franchi, Fabiana Rollini, Siva Suryadevara, Dominick J. Angiolillo, Latonya Been, Martin M. Zenni, Gary S. Roubin, Andrea Rivas, Theodore A. Bass and Andrés M. Pineda and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Daniel Soffer

28 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Soffer United States	13	439	214	105	85	41	30	508
Wael Sumaya United Kingdom	8	269 0.6×	148 0.7×	93 0.9×	75 0.9×	34 0.8×	18	380
Hasan Arı Türkiye	11	444 1.0×	150 0.7×	59 0.6×	47 0.6×	35 0.9×	69	516
Adriana D. Oprea United States	10	194 0.4×	187 0.9×	41 0.4×	85 1.0×	23 0.6×	28	382
Salvatore Colangelo Italy	11	540 1.2×	385 1.8×	110 1.0×	64 0.8×	25 0.6×	21	631
Peter J. Casterella United States	7	350 0.8×	218 1.0×	144 1.4×	64 0.8×	16 0.4×	13	482
Emmanuel I. Skalidis Greece	15	601 1.4×	175 0.8×	30 0.3×	93 1.1×	59 1.4×	39	723
Tahsin Bozat Türkiye	11	308 0.7×	106 0.5×	30 0.3×	37 0.4×	34 0.8×	46	358
Kazunori Iwade Japan	7	271 0.6×	71 0.3×	55 0.5×	65 0.8×	115 2.8×	14	363
Harumi Katoh Japan	14	432 1.0×	153 0.7×	28 0.3×	150 1.8×	44 1.1×	31	600
Martin Poloczek Czechia	11	278 0.6×	155 0.7×	20 0.2×	45 0.5×	31 0.8×	43	375

Countries citing papers authored by Daniel Soffer

Since Specialization

Citations

This map shows the geographic impact of Daniel Soffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Soffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Soffer more than expected).

Fields of papers citing papers by Daniel Soffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Soffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Soffer. The network helps show where Daniel Soffer may publish in the future.

Co-authorship network of co-authors of Daniel Soffer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Soffer. A scholar is included among the top collaborators of Daniel Soffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Soffer. Daniel Soffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kessler, Asia Sikora, et al.. (2025). Healthcare utilization and expenditures among adults with severe hypertriglyceridemia in US clinical practice. Journal of clinical lipidology. 19(3). e119–e120. 1 indexed citations

Kessler, Asia Sikora, et al.. (2025). Risk of acute pancreatitis among patients with hypertriglyceridemia (HTG) or severe hypertriglyceridemia (sHTG). Journal of clinical lipidology. 19(3). e67–e67.

Kessler, Asia Sikora, et al.. (2025). Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practice. Lipids in Health and Disease. 24(1). 252–252. 1 indexed citations

Ortega‐Paz, Luis, Francesco Franchi, Fabiana Rollini, et al.. (2024). Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD. JACC Basic to Translational Science. 9(7). 865–876. 2 indexed citations

Franchi, Francesco, Luis Ortega‐Paz, Fabiana Rollini, et al.. (2023). Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study.. PubMed. 18(15). 1254–1265. 9 indexed citations

Ortega‐Paz, Luis, Francesco Franchi, Fabiana Rollini, et al.. (2023). Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study. Thrombosis and Haemostasis. 124(3). 263–273. 9 indexed citations

Franchi, Francesco, Fabiana Rollini, Luis Ortega‐Paz, et al.. (2023). Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 16(20). 2528–2539. 10 indexed citations

Galli, Mattía, Francesco Franchi, Fabiana Rollini, et al.. (2022). Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy. European Heart Journal - Cardiovascular Pharmacotherapy. 8(7). 728–737. 17 indexed citations

Franchi, Francesco, Luis Ortega‐Paz, Fabiana Rollini, et al.. (2022). Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor. JACC: Cardiovascular Interventions. 16(1). 36–46. 18 indexed citations

10.

Galli, Mattía, Francesco Franchi, Fabiana Rollini, et al.. (2022). Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease. Thrombosis and Haemostasis. 122(8). 1341–1351. 21 indexed citations

11.

Franchi, Francesco, Fabiana Rollini, Latonya Been, et al.. (2021). Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease. European Heart Journal - Cardiovascular Pharmacotherapy. 8(5). 452–461. 5 indexed citations

12.

Franchi, Francesco, Fabiana Rollini, Andrea Rivas, et al.. (2020). Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes. JACC Basic to Translational Science. 5(5). 419–428. 23 indexed citations

13.

Franchi, Francesco, Fabiana Rollini, Yongwhi Park, et al.. (2019). Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine. JACC: Cardiovascular Interventions. 12(16). 1538–1549. 29 indexed citations

14.

Kairouz, Victor, Francesco Franchi, Siva Suryadevara, et al.. (2018). CANGRELOR AS AN ANTIPLATELET BRIDGING STRATEGY IN PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING CARDIAC AND NON-CARDIAC SURGERY. Journal of the American College of Cardiology. 71(11). A75–A75. 4 indexed citations

15.

Franchi, Francesco, Fabiana Rollini, Yongwhi Park, et al.. (2016). Abstract 19115: Effect of the Peripheral Opioid Receptor Antagonist Methylnaltrexone on the Pharmacokinetic and Pharmacodynamic Profiles of Ticagrelor in Patients Receiving Morphine: A Prospective Randomized Placebo-Controlled Trial. Circulation. 134. 2 indexed citations

16.

Jelnin, Vladimir, et al.. (2009). Images in Cardiology: Postpartum Intramural Hematoma—Evaluation by Computed Tomographic Angiography. Journal of Clinical Hypertension. 11(11). 656–656. 3 indexed citations

17.

Chiam, Paul T.L., Gary S. Roubin, Sriram S. Iyer, et al.. (2008). Carotid artery stenting in elderly patients: Importance of case selection. Catheterization and Cardiovascular Interventions. 72(3). 318–324. 54 indexed citations

18.

Hanzel, George, et al.. (2005). Prospective Evaluation of Aggressive Medical Therapy for Atherosclerotic Renal Artery Stenosis, With Renal Artery Stenting Reserved for Previously Injured Heart, Brain, or Kidney. The American Journal of Cardiology. 96(9). 1322–1327. 17 indexed citations

19.

Soffer, Daniel, Issam Moussa, Kishore J. Harjai, et al.. (2003). Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris. The American Journal of Cardiology. 91(7). 872–875. 12 indexed citations

20.

Soffer, Daniel, William W. O’Neill, Kishore J. Harjai, et al.. (2002). Inter-assay variability in the degree of platelet inhibition following GPIIb/IIIa receptor blockade in patients undergoing coronary intervention: a comparison of three different point-of-care assays. Journal of the American College of Cardiology. 39. 72–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact